ClariVest Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

ClariVest Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$4.7K	Hold	44	–	–	﹤0.01%	455
2024 Q2	$4.7K	Buy	44 +28	+175%	+$3.08K	﹤0.01%	455
2024 Q1	$1.93K	Hold	16	–	–	﹤0.01%	578
2023 Q4	$1.97K	Hold	16	–	–	﹤0.01%	555
2023 Q3	$2K	Buy	+16	New	+$2.13K	﹤0.01%	508
2021 Q3	–	Sell	-2,128	Closed	-$378K	–	788
2021 Q2	$378K	Hold	2,128	–	–	0.01%	455
2021 Q1	$350K	Sell	2,128 -1	-0%	-$165	0.01%	455
2020 Q4	$352K	Buy	2,129 +2,100	+7,241%	+$313K	0.01%	441
2020 Q3	$4K	Buy	+29	New	+$3.6K	﹤0.01%	570
2019 Q1	–	Sell	-15	Closed	-$2K	–	742
2018 Q4	$2K	Hold	15	–	–	﹤0.01%	651
2018 Q3	$3K	Sell	15 -2,900	-99%	-$499K	﹤0.01%	662
2018 Q2	$503K	Hold	2,915	–	–	0.01%	508
2018 Q1	$440K	Sell	2,915 -410	-12%	-$60.1K	0.01%	513
2017 Q4	$447K	Hold	3,325	–	–	0.01%	502
2017 Q3	$487K	Hold	3,325	–	–	0.01%	387
2017 Q2	$517K	Hold	3,325	–	–	0.01%	384
2017 Q1	$483K	Sell	3,325 -235	-7%	-$30.6K	0.01%	391
2016 Q4	$389K	Buy	3,560 +297	+9%	+$33.1K	0.01%	423
2016 Q3	$395K	Buy	3,263 +3,260	+108,667%	+$439K	0.01%	414
2016 Q2	$0	Hold	3	–	–	﹤0.01%	656
2016 Q1	$0	Hold	3	–	–	﹤0.01%	642
2015 Q4	$0	Hold	3	–	–	﹤0.01%	637
2015 Q3	$0	Sell	3 -2	-40%	-$344	﹤0.01%	626
2015 Q2	$1K	Hold	5	–	–	﹤0.01%	573
2015 Q1	$1K	Hold	5	–	–	﹤0.01%	569
2014 Q4	$1K	Hold	5	–	–	﹤0.01%	520
2014 Q3	$1K	Hold	5	–	–	﹤0.01%	543
2014 Q2	$1K	Hold	5	–	–	﹤0.01%	541
2014 Q1	$1K	Buy	+5	New	+$753	﹤0.01%	555

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClariVest Asset Management's JAZZ Position: Q3 2024 in Review

ClariVest Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2024 at 44 shares worth $4.7K. The position accounts for ﹤0.01% of the portfolio, ranked #455.

ClariVest Asset Management first reported a position in JAZZ in Q1 2014 and has held it in 29 quarters since. The position peaked at $517K in Q2 2017. 477 funds tracked by Wall St. Rank hold JAZZ as of Q3 2024.

ClariVest Asset Management held 44 shares of Jazz Pharmaceuticals worth $4.7K as of Q3 2024.
ClariVest Asset Management left its Jazz Pharmaceuticals share count unchanged in Q3 2024.
Jazz Pharmaceuticals made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #455 holding.
ClariVest Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 29 quarters since.
ClariVest Asset Management's Jazz Pharmaceuticals position peaked at $517K in Q2 2017.
477 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.